Well Starts with Clean Colons

Screening for prostate cancer is crucial for early detection and to help provide the best possible outcome. It is especially important for Black men to be vigilant about screening, as they are disproportionately impacted by this cancer.

About 1 in 6 Black men will be diagnosed with prostate cancer in their lifetime, compared to 1 in 8 white men, according to a report from the American Cancer Society. Prostate cancer is the second leading cause of cancer death in Black men.

The American Cancer Society recommends that men at an average risk of developing prostate cancer begin screening when they are 50, but Black men should start earlier—at age 45 if they have no family history of prostate cancer, and at age 40 if any of their male relatives have had prostate cancer. Wellstar takes a personalized approach to cancer screenings, with clinicians discussing benefits versus risks of screening and helping patients evaluate their risk.

“Despite many physicians being aware of this and following this practice, Black men continue to be diagnosed with and die from metastatic prostate cancer. This is a trend that desperately needs to be reversed,” said Wellstar Primary Care Physician Dr. Earl Stewart. “We have adequate screening tools that do not even require a digital rectal examination.”

The Prostate-Specific Antigen (PSA) blood test is more accurate than the digital rectal examination in helping to detect prostate cancer, according to Dr. Stewart. Patients should also discuss family history with their relatives. “Patients knowing their family history is so crucial in having those discussions with primary care physicians to determine the best age at which to start screening,” Dr. Stewart said.

Screening for prostate cancer is as simple as making a preventive appointment with your primary care physician, discussing your family history with him or her, and having a PSA blood test. This test may be performed during an annual physical or wellness visit. Shared decision making between physician and patient is important to discuss your risk, your need for testing and next steps to take if your PSA level is elevated and concerning. Knowing your risk can save your life.

“I know many personally who are near and dear to me who had the disease and who unfortunately died from complications of metastatic prostate cancer,” Dr. Stewart said. “I know many more who lived because they had the conversation and dared to move forward with appropriate screening at the appropriate age.”

Learn more about prostate cancer care at Wellstar.

The gynecologic oncologists at Wellstar care for women at all stages of life, treating a variety of conditions with compassion and offering advanced care options. Our team are experts in treating cancers such as uterine, ovarian, cervical, vaginal and vulvar cancers. Here, we answer common questions about gynecologic cancer care with the help of Dr. Rosa Miller Polan, a gynecologic oncologist at Wellstar Cobb Medical Center. 

What is a gynecologic oncologist?

Gynecologic oncologists are specialists trained in the multidisciplinary management of patients with cancers of the female reproductive tract. Trained originally in obstetrics and gynecology, gynecologic oncologists treat patients with complex benign gynecologic issues, as well as gynecologic cancer patients who may need surgery, chemotherapy, immunotherapy or a combination of different treatments. 

When should you seek care?

Gynecologic cancers have different warning signs. When a person experiences concerning symptoms, a physical exam, including a pelvic exam, should be performed. Cervical and vaginal cancer symptoms include abnormal vaginal discharge, vaginal bleeding and pain. The most common warning sign for uterine cancer is abnormal vaginal bleeding. In postmenopausal women, any bleeding or spotting is abnormal and should prompt an evaluation. 

Ovarian or fallopian tube cancer symptoms include bloating, constipation, pelvic or abdominal pain and difficulty eating or feeling full quickly. Vulvar cancer symptoms include itching, burning, discoloration, and new bumps or lumps on the skin outside of the vagina. 

Who is at risk for developing gynecologic cancer?

Women who smoke cigarettes are at elevated risk for cervical, vaginal and vulvar cancer development. People who are immunosuppressed and those who have tested positive for the human papillomavirus (HPV) are also at increased risk. Genetics can contribute to the development of uterine, ovarian or fallopian tube cancers and these types of cancers can run in families. Obesity and use of hormone replacement therapy can put women at risk for the development of uterine, ovarian and fallopian tube cancers. A history of infertility, endometriosis and pelvic radiation are also risk factors for developing gynecologic cancer. 

What services are available at Wellstar?

At Wellstar, gynecologic oncologists provide comprehensive care for patients with gynecologic cancers, including administering chemotherapy and performing surgeries when needed. As high-volume pelvic surgeons, gynecologic oncologists also care for patients who need elective and emergent complex benign gynecologic surgery.

For many patients, robotic-assisted surgery offers a minimally invasive approach with less associated blood loss, shorter hospital stays and fewer post-operative complications. Gynecologic oncologists are some of the top users of the innovative DaVinci 5 robotic surgery platform. Performing complex gynecologic cancer surgeries, minimally invasive or otherwise, requires the type of highly specialized and multidisciplinary teams that work at Wellstar—and an infrastructure of resources to ensure patients have access to best-in-class care in their own backyard.

Learn more about gynecologic oncology at Wellstar at wellstar.org/gyncancer.